Sotac Pharmaceuticals Limited — Others, 08-01-2025: Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter

Sotac Pharmaceuticals Limited has confirmed its exemption from filing quarterly, half-yearly, and yearly Corporate Governance Reports under Regulation 27(2) of the SEBI Listing Obligations and Disclosure Requirements. This non-applicability is due to meeting criteria set forth in Regulation 15(2)(b), as the company’s shares are listed on the SME Emerge Platform.

This development may streamline compliance requirements, potentially allowing the company to allocate resources more effectively. Investors might view this as a positive outlook for operational efficiency, though they should remain aware of any governance implications in the future.